Skip to content
Free shipping over $150 · $50 minimum order · Ships in 1–3 business days · COA for every lot
Log in
Peptides 99.924% purity Research Use Only · Not for Human or Veterinary Consumption

Tirzepatide (GLP-2) 30 mg

Tirzepatide (GLP-2) 30 mg supplied as a lyophilised vial. Tested at 99.924% purity by an independent laboratory. Certificate published under lot #149045.

Purity
99.924% HPLC
Mol. weight
4813 g/mol
Current lot
#149045 COA →
$189.99 $129.99 per vial, 30 mg

Quantity — volume pricing

30 ml +$14.99
In stock Lot #149045 View COA → $50 minimum order

At a glance

98+

Third-party purity

Every lot has a certificate from an independent laboratory, typically for HPLC purity and identity.

1–3

Business days to dispatch

Orders are usually prepared for shipment within 1–3 business days, then tracked end to end.

COA

Published before purchase

Read the latest certificate for the compound before you place the order, not after.

Certificate of analysis

The laboratory's report for the current lot

The certificate of analysis an independent laboratory issued for the lot listed here: typically purity by HPLC and identity, and endotoxins where the laboratory tested them.

Lot #149045
Purity 99.924% HPLC
Identity Confirmed by HPLC · 36.67 mg per vial
Laboratory Janoshik
Tested April 20, 2026

Specification

Purity
99.924% by HPLC
CAS number
2023788-19-2
Molecular weight
4813 g/mol
Molecular formula
C225H348N48O68
Physical form
Lyophilised powder
Net quantity
30 mg per vial
Current lot
#149045
Tested by
Janoshik
SKU
PFL-TIRZEPATIDE-30-MG

Storage & reconstitution

Before opening

Lyophilised powder is stable at ambient temperature in transit. On arrival, keep sealed vials refrigerated at 2–8 °C, dry and dark. For storage beyond three months, keep at −20 °C.

Reconstitution

Follow your laboratory's own protocol.

After reconstitution

Refrigerate at 2–8 °C and protect from light. Use within 30 days. Discard if the solution becomes cloudy or discoloured.

For laboratory research use only. Not for human or veterinary consumption. Not a drug or dietary supplement.

Research record

Three characterised lines of work

Tirzepatide (LY3298176), here in 30 mg vials, is a single synthetic peptide, modified with a fatty acid, that acts as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and the glucagon-like peptide-1 (GLP-1) receptors. It was designed to be long-acting, to test whether GIP-receptor activity adds to the metabolic actions of selective GLP-1 receptor agonists.

01

Dual incretin agonism

In cell lines expressing the incretin receptors the peptide activated both GIP and GLP-1 receptor signalling, and in mice it increased glucose-dependent insulin secretion and improved glucose tolerance by acting on both receptors. Given chronically to mice it decreased body weight and food intake more than a selective GLP-1 receptor agonist.

02

Imbalanced and biased

Receptor occupancy calculated for clinically studied doses shows greater engagement of the GIP receptor than of the GLP-1 receptor. At the GIP receptor the peptide mimics native GIP; at the GLP-1 receptor it favours cAMP generation over β-arrestin recruitment and drives less receptor internalisation than GLP-1. In primary islets β-arrestin 1 limited the insulin response to GLP-1 but not to GIP or tirzepatide.

03

Gastric emptying

Like the GLP-1 receptor agonists, the peptide slows gastric emptying; the delay is greatest at first and lessens with continued exposure. Reviews discuss the consequences for the absorption of oral drugs taken alongside, oral contraceptives among them, and for retained gastric contents at endoscopy or anaesthesia.

Published research areas

Research area Assay
Incretin receptor signalling cAMP accumulation and β-arrestin recruitment at the GIP and GLP-1 receptors
Receptor trafficking GLP-1 receptor internalisation assays
Islet function Glucose-dependent insulin secretion in primary islets
Energy balance Body weight and food intake in mice

Tirzepatide is the active ingredient of medicines approved in the United States, the European Union and Japan for type 2 diabetes and for chronic weight management. Those approvals apply to the licensed pharmaceutical products, not to research material such as this vial. In the trial programmes behind them the most common adverse events were gastrointestinal.

Regulatory status as of October 2026.

Structure

Tirzepatide (GLP-2) 30 mg 2D structure

2D structure · PubChem CID 166567236

References

  1. 1 Coskun T et al. (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept. Mol Metab. 10.1016/j.molmet.2018.09.009
  2. 2 Willard FS et al. (2020) Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight. 10.1172/jci.insight.140532
  3. 3 Skelley JW et al. (2024) The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception. J Am Pharm Assoc. 10.1016/j.japh.2023.10.037
  4. 4 Jalleh RJ et al. (2024) Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide. J Clin Endocrinol Metab. 10.1210/clinem/dgae719
  5. 5 Frías JP et al. (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 10.1056/NEJMoa2107519
  6. 6 Jastreboff AM et al. (2022) Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 10.1056/NEJMoa2206038
  7. 7 France NL, Syed YY (2024) Tirzepatide: a review in type 2 diabetes. Drugs. 10.1007/s40265-023-01992-4
  8. 8 Hamza M, Papamargaritis D, Davies MJ (2025) Tirzepatide for overweight and obesity management. Expert Opin Pharmacother. 10.1080/14656566.2024.2436595

Common questions

Ordering, handling and compliance. Anything not covered here, write to support@pureforgelabs.com.

What does research use only actually mean?

Every compound we sell is supplied for laboratory research and development only. It is not a drug, not a supplement, and not intended to diagnose, treat, cure or prevent any condition in humans or animals. Buying from this site means you are acquiring it for in vitro or other controlled research work.

Who is allowed to order?

Purchasers must be 21 or older and are responsible for compliance with the law where they take delivery. We ship to research institutions, laboratories and qualified individual researchers in the United States only. We do not ship to jurisdictions where these compounds are restricted.

How do I read the certificate of analysis?

Check three things in order. First, the lot code on the certificate matches the lot listed on the product page and in your order. Second, where the report gives an HPLC purity, its chromatogram shows a single dominant peak at the stated figure; a blend's report shows a peak for each compound. Third, where the lab ran mass spectrometry, the measured mass matches the expected molecular weight of the compound. Anything that does not line up, send us the lot code.

How should it be stored?

Unopened vials keep at ambient temperature short term, as in transit; on arrival, refrigerate them at 2–8 °C, and keep them at −20 °C beyond three months. Reconstitute following your laboratory's own protocol; once in solution, refrigerate at 2–8 °C, protect from light and use within 30 days.

When does it ship and how?

Orders are normally prepared for shipment within 1–3 business days and ship to street addresses in the United States only — not to P.O. boxes or APO/FPO/DPO military addresses. Shipping is free on orders over $150 and a flat $14.95 below that.

What payment methods do you take?

We take credit and debit cards, paid securely at checkout. Bank transfers and purchase orders are not available at the moment.

What if a vial arrives damaged?

Keep the vial and all the packaging, photograph the damage and email support@pureforgelabs.com within 48 hours of delivery with your order number. Once the claim is verified, we replace the vial or refund what you paid for it. Please do not send anything back unless we ask you to — apart from damaged or incorrect items, all sales are final.

Do you handle bulk and wholesale orders?

Yes, by quote. The volume tiers on the product pages go up to five vials; for larger research quantities email support@pureforgelabs.com with the compounds and amounts, and we will quote per gram.

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY CONSUMPTION. This product is intended solely for legitimate laboratory, analytical, and scientific research. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease and is not intended for human or veterinary administration or consumption. All products are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.

$129.99
Tirzepatide (GLP-2) 30 mg · 30 mg · 1 vial

New compounds, restocks, lot releases.

One short email when something changes. No drip campaigns.